|
03/11/2017 |
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
CIM |
Registered |
|
17/02/2017 |
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
CIM |
Registered |
|
15/08/2017 |
Homeostec for chronic arthritis |
SSA |
Registered |
|
15/08/2017 |
Bioactive formulation to treat osteoarthritis |
SSA |
Registered |
|
28/11/2017 |
Bioequivalence of Digoxin |
CIDEM |
Registered |
|
28/05/2020 |
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis |
BIOCEN |
Registered |
|
07/03/2018 |
14F7 in chronic B-cell lymphoproliferative syndrome |
CIM |
Registered |
|
05/08/2021 |
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib |
ROCHE |
Registered |
|
15/11/2016 |
EC122 HER-1 Prostate Phase I |
CIM |
Registered |
|
07/12/2016 |
NGcGM3/VSSP in Metastatic melanoma |
CIM |
Registered |
|
11/10/2013 |
Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba. |
FINLAY |
Registered |
|
13/09/2013 |
Coffee-bioavailability-cardiovascular health |
kmunoz |
Registered |
|
13/09/2013 |
Policosanol for long term-Ictus |
CPN |
Registered |
|
20/09/2013 |
Prevenox on osteoarthritis |
CPN |
Registered |
|
20/09/2013 |
Abexol + Prevenox in Osteoarthritis |
CPN |
Registered |
|
31/10/2013 |
Heptavalent Conjugate Vaccine against Pneumococcal (VCN7-T) in healthy infants and children. |
CQB |
Registered |
|
15/08/2014 |
Effects of D-003 and Omega-3 in women with osteoporosis |
CPN |
Registered |
|
15/03/2023 |
Evaluation of the effectiveness of video games for attention intervention in school age boys and girls |
CNEURO |
Registered |
|
22/04/2014 |
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. |
CNCMA |
Registered |
|
23/05/2014 |
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. |
CIM |
Registered |
